{
  "paper_metadata": {
    "pmid": "30662270",
    "title": "MAIN TEXT",
    "extraction_summary": "The paper primarily discusses a case report of a patient with BRAF-mutated metastatic colorectal cancer. A BRCA2 variant is mentioned in the context of genetic testing results, but no detailed penetrance or functional data is provided for BRCA2."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": null,
      "protein_notation": "p.Asp306Val",
      "genomic_position": null,
      "clinical_significance": "VUS",
      "patients": {
        "count": 1,
        "demographics": "44-year-old male",
        "phenotype": "metastatic colorectal cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": 0,
        "uncertain_count": 0,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_1",
          "age_at_evaluation": 44,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "metastatic colorectal cancer",
          "evidence_sentence": "NGS testing identified BRAFV600E mutation with extended wild-type RAS. Other genetic anomalies identified by NGS included the following mutations and amplifications: BRCA2D306V, ATMR337C, L1814F, RNF43R132, TP53R248W, Myc (copy number increase), and MCL1 (copy number increase)."
        }
      ],
      "functional_data": {
        "summary": "No functional data provided for BRCA2D306V.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "low",
      "source_location": "Case presentation, paragraph 4",
      "additional_notes": "The clinical relevance of the BRCA2D306V variant in CRC is not established.",
      "key_quotes": [
        "NGS testing identified BRAFV600E mutation with extended wild-type RAS. Other genetic anomalies identified by NGS included the following mutations and amplifications: BRCA2D306V, ATMR337C, L1814F, RNF43R132, TP53R248W, Myc (copy number increase), and MCL1 (copy number increase)."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [
      "Limited information on BRCA2 variant significance and penetrance."
    ],
    "notes": "The paper focuses on BRAF mutations in colorectal cancer, with limited data on BRCA2."
  }
}